187 related articles for article (PubMed ID: 8763422)
1. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas.
Schmid P; Itin P; Rufli T
Br J Dermatol; 1996 Jun; 134(6):1044-51. PubMed ID: 8763422
[TBL] [Abstract][Full Text] [Related]
2. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
3. [Distribution and expression of transforming growth factor beta and their receptors in hypertrophic scar].
Lu L; Chen YL; Zhang QG
Zhonghua Shao Shang Za Zhi; 2004 Feb; 20(1):30-3. PubMed ID: 15059449
[TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
Matoba H; Sugano S; Yamaguchi N; Miyachi Y
Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
7. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds.
Cowin AJ; Holmes TM; Brosnan P; Ferguson MW
Eur J Dermatol; 2001; 11(5):424-31. PubMed ID: 11525949
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.
Bedossa P; Peltier E; Terris B; Franco D; Poynard T
Hepatology; 1995 Mar; 21(3):760-6. PubMed ID: 7875675
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.
Friess H; Yamanaka Y; Büchler M; Berger HG; Kobrin MS; Baldwin RL; Korc M
Cancer Res; 1993 Jun; 53(12):2704-7. PubMed ID: 8389240
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis.
Gold LI; Jussila T; Fusenig NE; Stenbäck F
J Pathol; 2000 Apr; 190(5):579-88. PubMed ID: 10727984
[TBL] [Abstract][Full Text] [Related]
12. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta s and TGF-beta type II receptor in human epidermis: differential expression in acute and chronic skin wounds.
Schmid P; Cox D; Bilbe G; McMaster G; Morrison C; Stähelin H; Lüscher N; Seiler W
J Pathol; 1993 Nov; 171(3):191-7. PubMed ID: 8277368
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.
Hazelbag S; Gorter A; Kenter GG; van den Broek L; Fleuren G
Hum Pathol; 2002 Dec; 33(12):1193-9. PubMed ID: 12514788
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation.
Tuli SS; Liu R; Chen C; Blalock TD; Goldstein M; Schultz GS
Curr Eye Res; 2006 Sep; 31(9):709-19. PubMed ID: 16966143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]